GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion-Reference-Cited by-同舟云学术

GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion

Published:2007-12-16 Issue:1 Volume:10 Page:85-92
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Morishige Masaki,Hashimoto Shigeru,Ogawa Eiji,Toda Yoshinobu,Kotani Hirokazu,Hirose Mayumi,Wei Shumei,Hashimoto Ari,Yamada Atsuko,Yano Hajime,Mazaki Yuichi,Kodama Hiroshi,Nio Yoshinori,Manabe Toshiaki,Wada Hiromi,Kobayashi Hidenori,Sabe Hisataka

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/ncb1672.pdf

Reference29 articles.

1. Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355–365 (2001).

2. Hynes, N. & Lane, H. ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Rev. Cancer 5, 341–354 (2005).

3. Hashimoto, S. et al. Requirement for Arf6 in breast cancer invasive activities. Proc. Natl Acad. Sci. USA 101, 6647–6652 (2004).

4. Onodera, Y. et al. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J. 24, 963–973 (2005).

5. Sabe, H. Requirement for Arf6 in cell adhesion, migration, and cancer cell invasion. J. Biochem. 134, 485–489 (2003).

Cited by 195 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a nomogram predicting overall survival based on ADAP2-related apoptosis genes in gliomas;International Immunopharmacology;2024-12

2. Tumour-intrinsic endomembrane trafficking by ARF6 shapes an immunosuppressive microenvironment that drives melanomagenesis and response to checkpoint blockade therapy;Nature Communications;2024-08-04

3. Association of ADP‑ribosylation factor family genes with prognosis and immune infiltration of breast cancer;Oncology Letters;2024-04-23

4. Membrane trafficking alterations in breast cancer progression;Frontiers in Cell and Developmental Biology;2024-03-12

5. VNP20009-Abvec-Igκ-MIIP suppresses ovarian cancer progression by modulating Ras/MEK/ERK signaling pathway;Applied Microbiology and Biotechnology;2024-02-19